Study of immunologic response after COVID-19 vaccination in kidney transplant recipients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210611006

Enrollment

Registered

2021-06-11

Start date

2021-05-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune response after COVID-19 vaccination in immunosuppressed patients Covid-19 vaccine kidney transplant immunosuppression

Interventions

Kidney transplant recipients with immunosuppressive drugs and plan for COVID vaccine were enrolled

Screening

Kidney Transplant Recipient

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age > 18 - kidney transplant > 6 months

Exclusion criteria

Exclusion criteria: absolute lymphocyte count lower than 2,000 cells/microlitre rejection with in 6 months ABO incompatible kidney transplant combined organ transplantation previous kidney transplantation eGFR (CKD-EPI) lower than 40 mL/min/1.73m2 Panel reactive antibody (PRA) > 20% donor specific antibody positive active hepatitis B, hepatitis C, HIV poor controlled DM poor controlled hypertension poor controlled dyslipidemia history of malignancy history of BK virus nephropathy history of CMV disease pregnancy / lactation

Design outcomes

Primary

Measure	Time frame
Immune response after complete vaccine 4 weeks after complete vaccination Neutralizing antibody and T-cell response	—

Secondary

Measure	Time frame
Immune response after first dose 4 weeks after first dose Neutralizing antibody and T-cell response,Immune response after first dose 8 weeks after first dose Neutralizing antibody and T-cell response	—

Countries

Thailand

Contacts

Public ContactNatavudh Townamchai

Chulalongkorn University

ntownamchai@gmail.com0894904222

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026